DC Field | Value | Language |
dc.contributor.author | Spoială, Augustina | |
dc.date.accessioned | 2020-11-11T10:32:09Z | |
dc.date.available | 2020-11-11T10:32:09Z | |
dc.date.issued | 2020-10 | |
dc.identifier.uri | https://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii | |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/12856 | |
dc.description | State University of Medicine and Pharmacy "Nicolae Testemiteanu" Chișinău, Republic of Moldova, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltare | en_US |
dc.description.abstract | Introduction: MMPs are a family of
proteinases that regulate cell behavior by
remodeling stromal and cell surface
proteins, thereby influencing cell survival,
genomic stability, and differentiation.
MMPs are key players in the neoplastic
cells’ development and dissemination.
Material and methods: In order to achieve
the proposed goal, the publications from
the specialized journals of the PubMed,
Medline and Hinari electronic libraries
have been examined.
Purpose: To summarize the evidence
derived from international studies on
expression and involvement of
metalloproteinases in the tumor growth,
invasion, migration and angiogenesis to
identify potential therapeutic strategies.
Results: A positive correlation between tumor
progression and the expression of multiple MMPs in
tumor tissues has been demonstrated. There are
many reports showing that members of the ADAM
family are overexpressed in human cancers.
Protumor activities have also been reported for
ADAMTS-1 in mammary carcinomas, ADAMTS-12
in breast cancer cells, ADAMTS-4 and ADAMTS-5
in glioblastoma. Other ADAMTS metalloproteases
showing tumor-associated effects are ADAMTS-2,
ADAMTS-14 and ADAMTS-18.
Conclusions:Altered expression of MMPs,
ADAMs and ADAMTSs has been found in
diverse tumor types. However, the exact
role of these proteinases in the initiation or
progression of the disease is generally still
poorly elucidated. Specific inhibitors of
ADAM could be potential remedies in anticancer
therapy. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" din Republica Moldova | en_US |
dc.subject | metalloproteases | en_US |
dc.subject | ADAM | en_US |
dc.subject | ADAMTS | en_US |
dc.subject | cancer | en_US |
dc.subject | matrix metalloproteases | en_US |
dc.title | The role of metalloproteinases (MMPs) in tumor development | en_US |
dc.type | Other | en_US |
Appears in Collections: | Culegere de postere
|